Revvityブログ
発見から治療までのイノベーションを促進
Latest
Enhancing CAR NK-cell research with chemically defined serum-free culture solutions.
Cancer
December 5, 2025 - 3 min read
Cancer
The mixed lymphocyte reaction (MLR): a classic assay for modern drug immune assessment.
March 25, 2025 -
3 min read
Cancer
Utilizing AlphaLISA technology to elucidate CDK2 signaling pathways in CCNE-1 amplified ovarian cancer.
March 5, 2025 -
8 min read
Cancer
How Mimix™ Reference Standards are generated, and how they can support your oncology research.
February 28, 2025 -
7 min read
Cancer
Lentiviral sgRNA CRISPR screening in primary human immune cells.
February 19, 2025 -
2 min read
Cancer
Considerations for engineering a successful knockout cell line generation.
January 17, 2025 -
1 min read
Cancer
Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.
January 15, 2025 -
4 min read
Cancer
Homology-directed repair with a DNA donor oligo: considerations for successful HDR experimental design.
January 14, 2025 -
5 min read
Cancer
Tips on establishing a reliable cell free DNA (cfDNA) workflow from plasma samples.
November 26, 2024 -
6 min read
Physiological Model Solutions, Cancer
Why you should use 3D cell models for high throughput screening.
October 24, 2024 -
4 min read
